CD BioGlyco is the world's leading independent biotechnology company, attracting a large number of researchers and partners, and has provided high-quality products and services for thousands of researchers
Introduction
Glycogenomics, which combines genomics and glycomics, is transforming how researchers understand glycosylation and its impact on protein function and disease mechanisms. By studying the genes involved in glycan synthesis, glycogenomics helps identify novel drug targets and disease biomarkers.
With advancements in glycomics and genomics, glycogenomics platforms provide researchers...
CD BioGlyco, a biotechnology company focused on the advancement of glycobiology, reported the launch of its new Glycan Microarray Assay service, which is a solution to a long-standing problem in glycan analysis and research. Glycans have an important role, yet their study has been challenging due to the lack of flexible tools to analyze these very small and diverse structures.
CD...